Evidence map›Paper›PMID 29666415›Full record

ArticleNature communications2018

Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis.

Maria C Silva, Marcela Davoli-Ferreira, Tiago S Medina, Renata Sesti-Costa, Grace K Silva, Carla D Lopes, Lucas E Cardozo, Fábio N Gava, Konstantina Lyroni, Fabrício C Dias and 12 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Immunopathogenesis inFrontiers in immunology · 2023
    Review
  7. Review
  8. Review
  9. Article
  10. Observational
  11. Transcriptional Studies onFrontiers in cellular and infection microbiology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Search of Allosteric Inhibitors and Associated Proteins of an AKT-International journal of molecular sciences · 2018
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 5 countries.

Maria C SilvaDepartment of Pharmacology, Ribeirão Preto Medical School, University of Sao Paulo, Bandeirantes Avenue, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
Marcela Davoli-FerreiraDepartment of Pharmacology, Ribeirão Preto Medical School, University of Sao Paulo, Bandeirantes Avenue, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
Tiago S MedinaDepartment of Biochemistry and Immunology, Fiocruz- Bi-Institutional Translational Medicine Plataform, Ribeirão Preto Medical School, University of Sao Paulo, Bandeirantes Avenue, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
Renata Sesti-CostaDepartment of Biochemistry and Immunology, Fiocruz- Bi-Institutional Translational Medicine Plataform, Ribeirão Preto Medical School, University of Sao Paulo, Bandeirantes Avenue, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
Grace K SilvaDepartment of Biochemistry and Immunology, Fiocruz- Bi-Institutional Translational Medicine Plataform, Ribeirão Preto Medical School, University of Sao Paulo, Bandeirantes Avenue, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
Carla D LopesDepartment of Biochemistry and Immunology, Fiocruz- Bi-Institutional Translational Medicine Plataform, Ribeirão Preto Medical School, University of Sao Paulo, Bandeirantes Avenue, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
Lucas E CardozoDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, 05508-900, Brazil.
Fábio N GavaDepartment of Physiology, Ribeirão Preto Medical School, University of Sao Paulo, Bandeirantes Avenue, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
Konstantina LyroniLaboratory of Clinical Chemistry, School of Medicine, University of Crete, 71003, Heraklion, Greece.
Fabrício C DiasDepartment of Biochemistry and Immunology, Fiocruz- Bi-Institutional Translational Medicine Plataform, Ribeirão Preto Medical School, University of Sao Paulo, Bandeirantes Avenue, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
Amanda F FradeLaboratory of Immunology, Heart Institute (InCor), School of Medicine, University of São Paulo, São Paulo, SP, 05403-900, Brazil.
Monique BaronLaboratory of Immunology, Heart Institute (InCor), School of Medicine, University of São Paulo, São Paulo, SP, 05403-900, Brazil.
Helder I NakayaDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, 05508-900, Brazil.ORCID http://orcid.org/0000-0001-5297-9108
Florêncio FigueiredoLaboratory of Pathology, School of Medicine, University of Brasilia, Campus Universitário Darcy Ribeiro, Brasilia, DF, 70910-900, Brazil.
José C Alves-FilhoDepartment of Pharmacology, Ribeirão Preto Medical School, University of Sao Paulo, Bandeirantes Avenue, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
Fernando Q CunhaDepartment of Pharmacology, Ribeirão Preto Medical School, University of Sao Paulo, Bandeirantes Avenue, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
Christos TsatsanisLaboratory of Clinical Chemistry, School of Medicine, University of Crete, 71003, Heraklion, Greece.ORCID http://orcid.org/0000-0003-1214-4151
Christophe ChevillardTAGC/INSERM U1090, Aix Marseille Université AMU, Parc Scientifique de Luminy case 928, 163 Avenue de Luminy, 13288, Marseille, Cedex 09, France.
Edecio Cunha-NetoLaboratory of Immunology, Heart Institute (InCor), School of Medicine, University of São Paulo, São Paulo, SP, 05403-900, Brazil.ORCID http://orcid.org/0000-0002-3699-3345
Emilio HirschMolecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, 10126, Italy.ORCID http://orcid.org/0000-0002-9073-6024
João S SilvaDepartment of Biochemistry and Immunology, Fiocruz- Bi-Institutional Translational Medicine Plataform, Ribeirão Preto Medical School, University of Sao Paulo, Bandeirantes Avenue, 3900, Ribeirão Preto, SP, 14049-900, Brazil. jsdsilva@fmrp.usp.br.
Thiago M CunhaDepartment of Pharmacology, Ribeirão Preto Medical School, University of Sao Paulo, Bandeirantes Avenue, 3900, Ribeirão Preto, SP, 14049-900, Brazil. thicunha@fmrp.usp.br.
Universidade de São Paulo · BRUniversity of Crete · GRInserm · FRUniversidade de Brasília · BRUniversidade de Ribeirão Preto · BRUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chagas disease is caused by infection with the protozoan Trypanosoma cruzi (T. cruzi) and is an important cause of severe inflammatory heart disease. However, the mechanisms driving Chagas disease cardiomyopathy have not been completely elucidated. Here, we show that the canonical PI3Kγ pathway is upregulated in both human chagasic hearts and hearts of acutely infected mice. PI3Kγ-deficient mice and mutant mice carrying catalytically inactive PI3Kγ are more susceptible to T. cruzi infection. The canonical PI3Kγ signaling in myeloid cells is essential to restrict T. cruzi heart parasitism and ultimately to avoid myocarditis, heart damage, and death of mice. Furthermore, high PIK3CG expression correlates with low parasitism in human Chagas' hearts. In conclusion, these results indicate an essential role of the canonical PI3Kγ signaling pathway in the control of T. cruzi infection, providing further insight into the molecular mechanisms involved in the pathophysiology of chagasic heart disease.

Indexed as

AdultAnimalsBiopsyCell LineChagas CardiomyopathyClass Ib Phosphatidylinositol 3-KinaseDisease Models, AnimalFemaleHeartHumansMaleMiceMice, Inbred C57BLMice, KnockoutMiddle AgedMyeloid Cells5-quinoxalin-6-ylmethylenethiazolidine-2,4-dioneClass Ib Phosphatidylinositol 3-KinasePhosphoinositide-3 Kinase InhibitorsPIK3CG protein, humanPik3cg protein, mouseQuinoxalinesThiazolidinediones

Identifiers

PMID29666415
PMCPMC5904108
OpenAlexW2806553033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.